Status:
RECRUITING
Early Life Intervention in Pediatrics Supported by E-health
Lead Sponsor:
Insel Gruppe AG, University Hospital Bern
Collaborating Sponsors:
University of Bern
Conditions:
Adiposity
Childhood Obesity
Eligibility:
All Genders
6-12 years
Phase:
NA
Brief Summary
Childhood obesity in early life contributes to the development of specific NCDs, i.e. adult obesity. Unhealthy diet and low level of physical activity are lifestyle risk behaviors associated with chro...
Detailed Description
ELIPSE-I represents a single-blind randomized controlled parallel-group clinical trial. In ELIPSE-I, 148 children, matched for sex, 6-12 years of age with a BMI \>97 centile based on national growth c...
Eligibility Criteria
Inclusion
- German speaking parents
- Any ethnic background/race
- Children should live/grow-up in the same household as the parental participant
- Children with an age- and sex-matched BMI \>97 centile according to Swiss national growth charts
- Children who newly attend the outpatient weight management clinic at the Division of Pediatric Endocrinology at the University Children's Hospital Bern
- Signed informed consent form from parent(s)
Exclusion
- Syndromic obesity
- Known congenital disease affecting musculo-skeletal, cardiac or pulmonary function
- Participation in another clinical trial targeting similar objectives
Key Trial Info
Start Date :
February 16 2024
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
December 31 2028
Estimated Enrollment :
148 Patients enrolled
Trial Details
Trial ID
NCT06208345
Start Date
February 16 2024
End Date
December 31 2028
Last Update
June 27 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Department of Paediatrics, Inselspital, Bern University Hospital
Bern, Switzerland, 3010